AU2016248366B2 - Heterocycles useful as IDO and TDO inhibitors - Google Patents
Heterocycles useful as IDO and TDO inhibitors Download PDFInfo
- Publication number
- AU2016248366B2 AU2016248366B2 AU2016248366A AU2016248366A AU2016248366B2 AU 2016248366 B2 AU2016248366 B2 AU 2016248366B2 AU 2016248366 A AU2016248366 A AU 2016248366A AU 2016248366 A AU2016248366 A AU 2016248366A AU 2016248366 B2 AU2016248366 B2 AU 2016248366B2
- Authority
- AU
- Australia
- Prior art keywords
- compound
- heterocyclyl
- cycloalkyl
- mmol
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 *=C([C@](C(CC(C1)C2)(CC1C1)CC21O)O)C(*1)[C@]1(c(c-1ccc2)c2F)[n]2c-1cnc2 Chemical compound *=C([C@](C(CC(C1)C2)(CC1C1)CC21O)O)C(*1)[C@]1(c(c-1ccc2)c2F)[n]2c-1cnc2 0.000 description 6
- NGIVETNIZRPABK-UHFFFAOYSA-N CC(C1(C2)CC(C3)CC2C3C1)=O Chemical compound CC(C1(C2)CC(C3)CC2C3C1)=O NGIVETNIZRPABK-UHFFFAOYSA-N 0.000 description 1
- JHTWJNYBNNKSKX-UHFFFAOYSA-N O=C(CC(c1c-2cccc1)[n]1c-2cnc1)C(CC1)CCN1c1ccccc1 Chemical compound O=C(CC(c1c-2cccc1)[n]1c-2cnc1)C(CC1)CCN1c1ccccc1 JHTWJNYBNNKSKX-UHFFFAOYSA-N 0.000 description 1
- NDOPHXWIAZIXPR-UHFFFAOYSA-N O=Cc(cccc1)c1Br Chemical compound O=Cc(cccc1)c1Br NDOPHXWIAZIXPR-UHFFFAOYSA-N 0.000 description 1
- MGMDIUIJNUBWAY-UHFFFAOYSA-N OC(CC(c1ccccc1-1)[n]2c-1cnc2)C(CC1)CCN1c1ccccc1 Chemical compound OC(CC(c1ccccc1-1)[n]2c-1cnc2)C(CC1)CCN1c1ccccc1 MGMDIUIJNUBWAY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562146340P | 2015-04-12 | 2015-04-12 | |
| US62/146,340 | 2015-04-12 | ||
| US201662274292P | 2016-01-02 | 2016-01-02 | |
| US62/274,292 | 2016-01-02 | ||
| PCT/CN2016/079104 WO2016165613A1 (en) | 2015-04-12 | 2016-04-12 | Heterocycles useful as ido and tdo inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2016248366A1 AU2016248366A1 (en) | 2017-11-30 |
| AU2016248366B2 true AU2016248366B2 (en) | 2019-06-13 |
Family
ID=57125732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016248366A Ceased AU2016248366B2 (en) | 2015-04-12 | 2016-04-12 | Heterocycles useful as IDO and TDO inhibitors |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10358451B2 (enExample) |
| EP (1) | EP3283488A4 (enExample) |
| JP (1) | JP2018511647A (enExample) |
| CN (1) | CN108026098B (enExample) |
| AU (1) | AU2016248366B2 (enExample) |
| WO (1) | WO2016165613A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105884828A (zh) * | 2015-02-16 | 2016-08-24 | 上海迪诺医药科技有限公司 | 多环化合物、其药物组合物及应用 |
| CA2981998A1 (en) * | 2015-04-21 | 2016-10-27 | Jiangsu Hengrui Medicine Co., Ltd. | Imidazo isoindole derivative, preparation method therefor and medical use thereof |
| CN115010712B (zh) * | 2015-12-24 | 2025-07-25 | 基因泰克公司 | Tdo2抑制剂 |
| CN107056785B (zh) * | 2016-01-02 | 2021-06-22 | 杭州英创医药科技有限公司 | 作为ido和tdo抑制剂的杂环化合物 |
| CN107556316B (zh) * | 2016-06-30 | 2021-11-12 | 鲁南制药集团股份有限公司 | 含桥环的咪唑衍生物 |
| WO2017198159A1 (zh) * | 2016-05-16 | 2017-11-23 | 鲁南制药集团股份有限公司 | 含桥环的咪唑衍生物 |
| CN107698594A (zh) * | 2016-08-09 | 2018-02-16 | 苏州国匡医药科技有限公司 | 吲哚胺2，3‑双加氧酶抑制剂及其在药学中的用途 |
| TW201815766A (zh) | 2016-09-22 | 2018-05-01 | 美商普雷辛肯公司 | 用於ｉｄｏ及ｔｄｏ調節之化合物及方法以及其適應症 |
| GB201701332D0 (en) * | 2017-01-26 | 2017-03-15 | Tc Biopharm Ltd | Immune cells with modified metabolism and their use thereof |
| BR102018007822A2 (pt) * | 2017-04-20 | 2018-11-06 | Gilead Sciences, Inc. | composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição |
| CN107176956B (zh) * | 2017-05-31 | 2019-11-12 | 成都海博锐药业有限公司 | 一种ido抑制剂化合物、药用组合物、用途 |
| WO2019005559A1 (en) * | 2017-06-28 | 2019-01-03 | Genentech, Inc. | INHIBITORS OF TDO2 AND IDO1 |
| EP3645537A1 (en) * | 2017-06-28 | 2020-05-06 | Genentech, Inc. | Tdo2 and ido1 inhibitors |
| CN107501272B (zh) * | 2017-09-05 | 2020-03-31 | 中国药科大学 | 咪唑并异吲哚类ido1抑制剂、其制备方法及应用 |
| CN108424414A (zh) * | 2017-12-08 | 2018-08-21 | 苏州国匡医药科技有限公司 | 一类含杂环的吲哚胺2，3-双加氧酶调节化合物及其在药学中的用途 |
| KR102708681B1 (ko) | 2018-02-13 | 2024-09-26 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
| US11149011B2 (en) | 2018-03-20 | 2021-10-19 | Plexxikon Inc. | Compounds and methods for IDO and TDO modulation, and indications therefor |
| WO2019231870A1 (en) | 2018-05-31 | 2019-12-05 | Merck Sharp & Dohme Corp. | Novel substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors |
| GB201809050D0 (en) | 2018-06-01 | 2018-07-18 | E Therapeutics Plc | Modulators of tryptophan catabolism |
| UA126421C2 (uk) | 2018-07-13 | 2022-09-28 | Гіліад Сайєнсіз, Інк. | Інгібітори pd-1/pd-l1 |
| AU2022228701A1 (en) | 2021-03-05 | 2023-09-14 | Universität Basel | Compositions for the treatment of ebv associated diseases or conditions |
| EP4052705A1 (en) | 2021-03-05 | 2022-09-07 | Universität Basel Vizerektorat Forschung | Compositions for the treatment of ebv associated diseases or conditions |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105884828A (zh) * | 2015-02-16 | 2016-08-24 | 上海迪诺医药科技有限公司 | 多环化合物、其药物组合物及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2694640T3 (enExample) | 2011-04-15 | 2018-03-17 | ||
| PE20151593A1 (es) | 2013-03-14 | 2015-11-05 | Newlink Genetics Corp | Compuestos triciclicos como inhibidores de la inmunosupresion mediada por el metabolismo del triptofano |
| AU2015311826B2 (en) | 2014-09-05 | 2019-05-23 | Merck Patent Gmbh | Cyclohexyl-ethyl substituted diaza- and triaza-tricyclic compounds as indole-amine-2,3-dioxygenase (IDO) antagonists for the treatment of cancer |
| GB201417369D0 (en) * | 2014-10-01 | 2014-11-12 | Redx Pharma Ltd | Compounds |
| CN105037371A (zh) | 2015-06-30 | 2015-11-11 | 西华大学 | 一种氘代的吲哚胺-2,3-双加氧酶抑制剂 |
-
2016
- 2016-04-12 CN CN201680033890.3A patent/CN108026098B/zh not_active Expired - Fee Related
- 2016-04-12 US US15/566,052 patent/US10358451B2/en active Active
- 2016-04-12 JP JP2017554522A patent/JP2018511647A/ja not_active Withdrawn
- 2016-04-12 EP EP16779588.9A patent/EP3283488A4/en not_active Withdrawn
- 2016-04-12 AU AU2016248366A patent/AU2016248366B2/en not_active Ceased
- 2016-04-12 WO PCT/CN2016/079104 patent/WO2016165613A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105884828A (zh) * | 2015-02-16 | 2016-08-24 | 上海迪诺医药科技有限公司 | 多环化合物、其药物组合物及应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| US10358451B2 (en) | 2019-07-23 |
| JP2018511647A (ja) | 2018-04-26 |
| US20180127418A1 (en) | 2018-05-10 |
| EP3283488A4 (en) | 2018-10-24 |
| AU2016248366A1 (en) | 2017-11-30 |
| CN108026098A (zh) | 2018-05-11 |
| EP3283488A1 (en) | 2018-02-21 |
| CN108026098B (zh) | 2019-09-03 |
| WO2016165613A1 (en) | 2016-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10358451B2 (en) | Heterocycles useful as IDO and TDO inhibitors | |
| KR102852841B1 (ko) | αvβ6 인테그린 억제 | |
| CA3224284A1 (en) | Kras g12d inhibitor and use thereof | |
| JP6760249B2 (ja) | 三環性スピロ化合物 | |
| JP7548814B2 (ja) | Ｉｄｏ阻害剤および／またはｉｄｏ－ｈｄａｃ二重阻害剤としての多環式化合物 | |
| CN116162099A (zh) | 杂环类衍生物及其制备方法和用途 | |
| CN116332938A (zh) | 稠合三环类衍生物及其制备方法和用途 | |
| WO2017101763A1 (en) | Heterocycles useful as anti-cancer agents | |
| CN109665968A (zh) | 并环化合物及其制备方法和用途 | |
| KR101925902B1 (ko) | Ｅ1 활성화 효소 억제제의 합성 방법 | |
| US5614518A (en) | Morpholine derivatives as dopamine receptor subtype ligands | |
| WO2015077194A1 (en) | Inhibitors of lysine methyl transferase | |
| KR102537615B1 (ko) | 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물 | |
| CA2877826A1 (en) | Tetrahydroquinazolinone derivatives as parp inhibitors | |
| WO2022161222A1 (zh) | 一类杂环类shp2抑制剂、其制备方法及用途 | |
| AU2022240688B2 (en) | Furan fused ring-substituted glutarimide compound | |
| EP2507221A1 (en) | Ship1 modulators and methods related thereto | |
| JPH11509541A (ja) | 新規なガランタミン誘導体、その製造方法、その医薬としての用途及びそれを含有する医薬組成物 | |
| CN111484491A (zh) | 取代吡啶并环化合物、其制备方法和用途 | |
| Lee et al. | Synthesis of 2, 4, 6, 8, 9, 11-hexaaza [3.3. 3] propellanes as a new molecular skeleton for explosives | |
| MXPA98000407A (en) | New derivatives of galantamine, its procedure for preparation, its application as medications and pharmaceutical compositions that conti | |
| CN109180681B (zh) | 一种dna毒性二聚体化合物 | |
| US9216977B2 (en) | Antofine and cryptopleurine derivatives as anticancer agents | |
| WO2005016000A1 (en) | Derivatives of cyclic quinone and uses thereof | |
| Caballero et al. | Stereochemical issues related to the synthesis and reactivity of pyrazino [2′, 1′-5, 1] pyrrolo [2, 3-b] indole-1, 4-diones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |